Iliana G.
- Country
- Bulgaria
- Department
- N/A
Research Overview
- Phase 3 Randomized Study on Efficacy and Safety of IVX-A12 Vaccine for RSV and hMPV in Adults Aged 60+
- Safety Evaluation of GSKVX000000025896 Versus Varicella Virus Oka/Merck Strain in Healthy Children Aged 12-15 Months
- Phase III Randomized, Observer-Blind Study on Safety and Immunogenicity of High-Dose Trivalent Influenza Vaccine in Adults Aged 60 and Above
Data & Insights
Has run more than one trial at 20 of 87 partner sites.
Specializations
Respiratory Virus Prevention
This investigator specializes in studying preventive measures against Respiratory Syncytial Virus (RSV) and Human Metapneumovirus (hMPV) infections, particularly in elderly populations aged 60 and above.
- RSV Lower Respiratory Tract Disease
- hMPV Infection Prevention
- Vaccine Development for Older Adults
The research focuses on innovative vaccine-based interventions using virus-like particle (VLP) technology for respiratory disease prevention.
Pediatric Immunization
The investigator conducts research in pediatric vaccination, with particular emphasis on varicella (chickenpox) prevention in young children aged 12 to 15 months.
- Childhood Vaccine Safety
- Vaccine Co-administration
- Immunization Schedule Optimization
Their work encompasses the evaluation of vaccine safety and reactogenicity when administered alongside other routine childhood immunizations.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.